The Korea Pharmaceutical Bio Association and GC Green Cross hold an open house for pharmaceutical bio at the Mokam Campus R&D Center
Jul 14, 2025
|
The open house event was held by 60 people, including the Ministry of Health and Welfare, the Health Insurance Review and Assessment Service, the Ministry of Food and Drug Safety, the Korea Health Industry Promotion Agency, the Science and Technology Commercialization Promotion Agency, and the association.
Since its completion in 2013, the GC Green Cross Neck Cancer Campus R&D Center has developed innovative drugs to address unmet medical needs in various treatment areas such as rare diseases and immune/inflammatory diseases, and has contributed to public health improvement by preventing infectious diseases. In addition, various pipelines are secured by strengthening expertise in major platforms such as plasma protein manufacturing technology, recombinant protein manufacturing technology, vaccine manufacturing technology, and next-generation mRNA/LNP manufacturing technology.
"We plan to continue operating open houses for various industrial sites such as pharmaceutical production facilities, research institutes, and museums. We expect this to serve as an opportunity to strengthen communication with the public sector and enhance understanding of the industry," the Pharmaceutical Bio Association said.
This article was translated by Naver AI translator.
